RARE is trading at $30.77, up 5.2% versus the comparison close of $29.25 during regular trading. This is a price-movement alert; no separate company-specific catalyst was searched for this follow-up.
🟢 RARE extends move to 5.2% up
Ultragenyx
Related News
RARE
Ultragenyx Announces FDA Full Approval for FAYUVIâ„¢, First-Ever Gene Therapy for MPS IIIA
RARE
🟢 Ultragenyx is trading 11.57% up today as XBI rises amid renewed M&A optimism
RARE
🟢 Ultragenyx is trading 5.5% up today amid a broad biotechnology rebound
RARE
🟢 Ultragenyx is trading 5% up today as rebound appears to reflect post-selloff trading
RARE